The director of the Oxford Vaccine Group on Monday said there was no link between the jab it developed with AstraZeneca and blood clotting, after several countries suspended its use. Andrew Pollard said there was “very reassuring evidence that there is no increase in a blood clot phenomenon here in the UK, where most of the doses in Europe been ...